Filing Details

Accession Number:
0001209191-19-044253
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-02 16:24:26
Reporting Period:
2019-07-31
Accepted Time:
2019-08-02 16:24:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1124140 Exact Sciences Corp EXAS Services-Commercial Physical & Biological Research (8731) 204782291
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1187406 J Daniel Levangie C/O Exact Sciences Corp.
441 Charmany Drive
Madison WI 53719
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-07-31 19,168 $3.43 31,626 No 4 M Direct
Common Stock Acquisiton 2019-07-31 7,667 $3.43 39,293 No 4 M Direct
Common Stock Acquisiton 2019-07-31 15,772 $8.52 55,065 No 4 M Direct
Common Stock Disposition 2019-07-31 2,828 $114.83 52,237 No 4 S Direct
Common Stock Disposition 2019-07-31 9,284 $115.65 42,953 No 4 S Direct
Common Stock Disposition 2019-07-31 2,300 $116.47 40,653 No 4 S Direct
Common Stock Disposition 2019-07-31 9,572 $117.72 31,081 No 4 S Direct
Common Stock Disposition 2019-07-31 9,626 $118.73 21,455 No 4 S Direct
Common Stock Disposition 2019-07-31 8,897 $119.63 12,558 No 4 S Direct
Common Stock Disposition 2019-07-31 100 $120.24 12,458 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2019-07-31 19,168 $0.00 19,168 $3.43
Common Stock Stock Option (right to buy) Disposition 2019-07-31 7,667 $0.00 7,667 $3.43
Common Stock Stock Option (right to buy) Disposition 2019-07-31 15,772 $0.00 15,772 $8.52
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2011-07-16 2020-07-16 No 4 M Direct
0 2011-07-16 2020-07-16 No 4 M Direct
0 2012-07-28 2021-07-28 No 4 M Direct
Footnotes
  1. Represents shares of common stock received upon exercise of a stock option award.
  2. The sales reported in this Column 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 25, 2019, a portion of which were sold to cover certain tax liabilities arising out of the vesting of shares of restricted stock.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.09 to $115.08, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.115 to $116.10, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.13 to $116.96, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.18 to $118.18, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
  7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.20 to $119.18, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.
  8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.23 to $120.23, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.